
The Hawks have dismantled an alleged Mandrax manufacturing laboratory worth an estimated R100 million in KwaZulu-Natal, arresting a 31-year-old suspect and seizing large quantities of drugs, chemicals and specialised manufacturing equipment.
The discovery at a property in Umvoti, near Kranskop, on Wednesday, November 18, is the latest major breakthrough in an escalating crackdown on clandestine drug manufacturing facilities across South Africa.
The operation was conducted by the Hawks’ South African Narcotics Enforcement Bureau (SANEB), working alongside Kranskop police, following an investigation into the proliferation of illegal drugs across provincial borders.

According to the Directorate for Priority Crime Investigation, officers acted on intelligence linking the suspect to an alleged drug manufacturing operation.
A search of the suspect’s premises and vehicle led to the discovery of Mandrax tablets and equipment allegedly used in the production of illicit drugs.
Among the items confiscated were a tablet-pressing machine, various chemicals used in drug manufacturing, specialised production equipment, Mandrax powder and finished tablets.
The seized drugs, chemicals and equipment have an estimated value exceeding R100 million.
The 31-year-old suspect is expected to appear before the Kranskop Magistrates’ Court on Friday, November 20, facing charges under the Drugs and Drug Trafficking Act 140 of 1992, including the alleged manufacturing of illicit drugs.
The latest bust comes as law enforcement agencies intensify investigations into what appears to be an expanding network of clandestine drug laboratories operating in different parts of the country.


In October, the Hawks uncovered another suspected Mandrax manufacturing laboratory at a farm in Hekpoort, near Krugersdorp, Gauteng.
That operation, also valued at approximately R100 million, resulted in the arrest of five South African men aged between 21 and 44.
Police discovered Mandrax and ecstasy tablets, two industrial pill-pressing machines, chemicals and other equipment allegedly used in manufacturing illegal substances.
Investigators were also examining possible connections between the different laboratories.
In September, two foreign nationals were arrested after the Hawks uncovered another alleged Mandrax manufacturing facility in Erasmia, west of Pretoria.
The laboratory was reportedly capable of producing approximately 800,000 Mandrax tablets daily. Police also discovered a separate facility where suspects were allegedly preparing to manufacture crystal methamphetamine.
The scale of these operations has raised concerns about the possible supply of locally manufactured drugs to markets beyond South Africa’s borders.
In October, the Hawks revealed that investigators were examining possible links between 11 drug laboratories uncovered nationally, with more than 30 suspects arrested at that stage.
Mandrax, which contains methaqualone, is a sedative drug with potentially serious health consequences. Its abuse can cause dependence, impaired judgement, respiratory depression and, in cases of overdose, death. When combined with alcohol or other depressants, the risks become even greater.
The proliferation of manufacturing facilities also presents challenges for communities, as illegal drug distribution fuels substance abuse, criminal activity and the exploitation of vulnerable people, particularly young users.
The Hawks have continued working with other law enforcement agencies to dismantle suspected drug manufacturing networks and establish the origins of chemicals used in production.
Investigations into the Umvoti laboratory are continuing, with authorities expected to establish whether the arrested suspect operated alone or was part of a wider distribution network.


